Display options
Cite
Doz P, Sperzel J. Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD). J Atr Fibrillation. 2016;8(5):1247doi: 10.4022/jafib.1247.
Doz, P., & Sperzel, J. (2016). Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD). Journal of atrial fibrillation, 8(5), 1247. https://doi.org/10.4022/jafib.1247
Doz, Priv, and Sperzel, Johannes. "Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD)." Journal of atrial fibrillation vol. 8,5 (2016): 1247. doi: https://doi.org/10.4022/jafib.1247
Doz P, Sperzel J. Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD). J Atr Fibrillation. 2016 Feb 29;8(5):1247. doi: 10.4022/jafib.1247. eCollection 2016. PMID: 27909469; PMCID: PMC5089482.
Copy Download .nbib Format: NLM
Share it on

J Atr Fibrillation. 2016 Feb 29;8(5):1247. doi: 10.4022/jafib.1247. eCollection 2016.

Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD).

Journal of atrial fibrillation

Priv Doz, Johannes Sperzel

Affiliations

  1. Kerckhoff-Klinik GmbH, Kardiologie, Elektrophysiologie, Bad Nauheim, Germany.

PMID: 27909469 PMCID: PMC5089482 DOI: 10.4022/jafib.1247

Abstract

Wearable cardioverter defibrillators (WCD), initially available in 2002, have recently experienced more routine use in many institutions as a means of preventing sudden cardiac death (SCD) prior to implantable cardioverter defibrillator (ICD) evaluation or implantation. WCD differ from ICD by their noninvasive nature, making them well suited for patient populations who have a chance for significant cardiac recovery (such as after an acute myocardial infarction). Despite their noninvasive nature, WCD treatment of sustained ventricular tachyarrhythmias is highly successful. An additional feature is the use of response buttons, which reduces the number of conscious shocks. Duration of use varies by condition but is typically several weeks to several months. Numerous studies have shown good compliance with WCD use and excellent efficacy. Although few prospective studies have been published, several are in progress including a randomized control trial of high risk patients after myocardial infarction. WCD use is rapidly gaining popularity for patients with recent myocardial infarction, recent-onset cardiomyopathies, and acute or subacute myocarditis. Surgical delays in implanting an indicated ICD or after ICD removal are also common. WCD removal occurs when the patient either qualifies for an ICD implantation or is determined to no longer have elevated SCD risk.

Keywords: Implantable Cardioverter Defibrillator; Sudden Cardiac Death; Ventricular Tachyarrhythmia; Wearable Cardioverter Defibrillator

References

  1. N Engl J Med. 2004 May 20;350(21):2151-8 - PubMed
  2. J Am Coll Cardiol. 2002 Apr 17;39(8):1323-8 - PubMed
  3. Europace. 2013 Nov;15(11):1594-600 - PubMed
  4. Heart Rhythm. 2008 Jun;5(6):e1-62 - PubMed
  5. J Am Coll Cardiol. 2013 Nov 19;62(21):2000-7 - PubMed
  6. J Card Fail. 2006 Aug;12(6):407-12 - PubMed
  7. N Engl J Med. 1997 Nov 27;337(22):1576-83 - PubMed
  8. Am Heart J. 1989 Jan;117(1):151-9 - PubMed
  9. Circ Arrhythm Electrophysiol. 2013 Feb;6(1):117-28 - PubMed
  10. J Am Coll Cardiol. 2008 Aug 12;52(7):541-50 - PubMed
  11. Heart Rhythm. 2006 Apr;3(4):397-403 - PubMed
  12. Ann Emerg Med. 1993 Nov;22(11):1652-8 - PubMed
  13. Pacing Clin Electrophysiol. 2004 Jan;27(1):4-9 - PubMed
  14. N Engl J Med. 2002 Mar 21;346(12):877-83 - PubMed
  15. Circulation. 2013 Feb 19;127(7):854-60 - PubMed
  16. N Engl J Med. 2005 Jan 20;352(3):225-37 - PubMed
  17. BMC Cardiovasc Disord. 2012 Dec 12;12:123 - PubMed
  18. Pacing Clin Electrophysiol. 2010 Sep;33(9):1119-24 - PubMed
  19. Ann Intern Med. 1996 Jul 1;125(1):35-9 - PubMed
  20. Resuscitation. 1998 Jun;37(3):139-43 - PubMed
  21. N Engl J Med. 2008 Sep 4;359(10):1009-17 - PubMed
  22. Circulation. 2010 Dec 21;122(25):2645-52 - PubMed
  23. N Engl J Med. 1996 Dec 26;335(26):1933-40 - PubMed
  24. Resuscitation. 2013 Nov;84(11):1480-6 - PubMed
  25. Am J Cardiol. 1992 Jun 1;69(17):1458-66 - PubMed
  26. J Cardiovasc Electrophysiol. 2014 Jan;25(1):52-9 - PubMed
  27. Am J Cardiol. 2012 Mar 1;109(5):729-35 - PubMed
  28. JAMA. 2013 May 8;309(18):1903-11 - PubMed
  29. N Engl J Med. 2005 Jun 23;352(25):2581-8 - PubMed
  30. J Am Coll Cardiol. 2006 Jul 18;48(2):330-9 - PubMed
  31. Circulation. 2004 Mar 9;109(9):1082-4 - PubMed
  32. Circulation. 2015 Oct 27;132(17):1613-9 - PubMed
  33. Europace. 2014 Dec;16(12):1752-8 - PubMed
  34. Heart. 2001 May;85(5):499-504 - PubMed
  35. Pacing Clin Electrophysiol. 2010 Jun 1;33(6):742-6 - PubMed
  36. Heart Rhythm. 2014 Aug;11(8):1418-25 - PubMed
  37. Circulation. 2014 Jul 1;130(1):94-125 - PubMed
  38. Am J Cardiol. 2006 Apr 15;97(8):1255-61 - PubMed
  39. J Am Coll Cardiol. 2012 May 1;59(18):1604-15 - PubMed
  40. J Am Coll Cardiol. 2010 Jul 13;56(3):194-203 - PubMed
  41. N Engl J Med. 2009 Oct 8;361(15):1427-36 - PubMed
  42. Cardiol Clin. 2014 May;32(2):253-70 - PubMed
  43. Semin Dial. 2008 Jul-Aug;21(4):300-7 - PubMed
  44. Am J Cardiol. 1998 May 15;81(10):1253-6 - PubMed
  45. N Engl J Med. 2012 Dec 13;367(24):2275-83 - PubMed
  46. Eur Heart J. 2013 Aug;34(29):2230-42 - PubMed
  47. Eur Heart J. 2009 Nov;30(22):2758-67 - PubMed
  48. Heart Rhythm. 2013 Jun;10(6):838-46 - PubMed
  49. N Engl J Med. 2004 Dec 9;351(24):2481-8 - PubMed
  50. Pacing Clin Electrophysiol. 2003 Oct;26(10):2016-22 - PubMed
  51. Am J Cardiol. 2011 Dec 1;108(11):1632-8 - PubMed
  52. Pacing Clin Electrophysiol. 2013 Oct;36(10):1265-72 - PubMed

Publication Types